TO HOST INVESTOR PRESENTATION WEBCAST VANCOUVER, BC, Jan. 31, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company that manufactures pure, consistent and sustainable cannabinoids via yeast biosynthesis, today announced that it will host a webcast investor presentation on Thursday, February 3rd at 2:00 PM EST.
During the webcast, Willow's President and Chief Executive Officer Trevor Peters will provide a presentation through a PowerPoint discussion that will cover key areas of Willow's business. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal.
To listen to the webcast or to ask questions during the live event, please pre-register at the following link:
https://event.webcasts.com/starthere.jsp?ei=1522256&tp_key=5868b5db75
An archived version of the webcast and presentation will be available on the Company's website, www.willowbio.com/#investors.
About Willow Biosciences Inc.
Willow is a leading biotechnology company that develops and produces high-purity, plant derived ingredients for the consumer care, food and beverage, and pharmaceutical markets. Willow's FutureGrown™ biotechnology platform allows scale production of pure, consistent, and sustainable product to benefit both B2B and B2C customers. Willow's R&D team has a proven track record of developing and commercializing bio-based manufacturing processes and products for both the consumer and pharmaceutical industries.